2024-09-06 - Analysis Report
## CVS Stock Analysis Report

**Company Overview:** CVS Health Corporation (CVS) is a health care company that operates retail pharmacies, drug wholesale distribution, and health insurance businesses.

**Performance Analysis:**

1. **Relative Performance:**

   * CVS has underperformed the S&P 500 (VOO) significantly, with a cumulative return of -19.26% compared to VOO's 84.86%.
   * The current relative performance is -107.03%, meaning CVS has underperformed the S&P 500 by 107.03%. This indicates CVS's performance has been consistently worse than the broader market.

2. **Recent Price Movement:**

   * The closing price of CVS is $59.3.
   * The 5-day, 20-day, and 60-day moving averages are 57.63, 57.59, and 58.85 respectively.
   * The recent price movement shows a slight upward trend, with the 5-day and 20-day moving averages slightly below the current price.

3. **Technical Indicators:**

   * **RSI:** The RSI value of 68.01 indicates CVS is currently in the overbought territory, suggesting a potential pullback may be in order.
   * **PPO:** The PPO value of 0.18 shows a positive momentum, but it is not exceptionally strong.
   * **Relative Divergence:** The recent 20-day relative divergence is -11.1, indicating a short-term downward trend in CVS's performance relative to the market.
   * **Expected Return:** A 12.6% expected return over five years suggests potential for growth but should be considered alongside other factors.

4. **Recent Earnings & Outlook:**

   * CVS's most recent earnings report (2024-08-07) showed EPS of 1.83, exceeding the analyst estimate of 1.73. This indicates a positive performance compared to expectations.
   * However, the recent performance should be assessed in the context of the overall trend. The previous earnings reports (2024-05-01 and 2024-02-07) showed EPS below the analyst estimates, suggesting a possible trend of declining performance.

**Overall Analysis:**

CVS has been significantly underperforming the market and its recent relative divergence suggests a possible continued downtrend. The RSI indicates a potential pullback, while the PPO shows a positive momentum, but it's not strong. The latest earnings report shows positive performance, but this should be analyzed in the context of the overall trend of previous earnings reports. The expected return of 12.6% over five years suggests potential growth, but should be evaluated carefully. Overall, investors should be cautious and consider other factors before making any investment decisions. 
